Article metrics

Download PDFPDF

323 Systemic administration of ladiratuzumab vedotin alone or in combination with pembrolizumab results in significant immune activation in the tumor microenvironment in metastatic breast cancer patients

 

Online download statistics by month:

Online download statistics by month: November 2020 to January 2024

AbstractFullPdf
Nov 2020201026
Dec 202055015
Jan 202182012
Feb 20215208
Mar 202180027
Apr 202168018
May 202121013
Jun 20210012
Jul 20210018
Aug 20210018
Sep 20210013
Oct 202162026
Nov 202144023
Dec 202134014
Jan 202238010
Feb 20224405
Mar 202238015
Apr 202240010
May 202260016
Jun 202270020
Jul 202248010
Aug 202266013
Sep 202228018
Oct 202286024
Nov 20225009
Dec 20225807
Jan 202380021
Feb 20237208
Mar 20235008
Apr 20233407
May 20233205
Jun 20231407
Jul 202336011
Aug 20235009
Sep 20233008
Oct 202370017
Nov 202382014
Dec 20234802
Jan 20243001
Total19530518